JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4776
Babcock & Wilcox
BW
$894M
| $208K | ﹤0.01% |
35,999
+2,526
| +8% | +$13.8K |
2020 Q2
10 quarters
|
|
4777
Compañía de Cervecerías Unidas
CCU
$2.07B
| $208K | ﹤0.01% |
15,872
-106,295
| -87% | -$1.22M |
2014 Q4
32 quarters
|
|
4778
Centrus Energy
LEU
$3.22B
| $208K | ﹤0.01% |
6,409
+440
| +7% | +$16.8K |
2021 Q2
6 quarters
|
|
4779
Mercer International
MERC
$16.6M
| $208K | ﹤0.01% |
17,844
-10,421
| -37% | -$139K |
2016 Q1
27 quarters
|
|
|
APLS
4780
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $207K | ﹤0.01% |
4,000
-68,500
| -94% | -$3.63M |
2022 Q3
1 quarter
|
|
4781
CALL
Darden Restaurants
DRI
$22.8B
| $207K | ﹤0.01% |
+1,500
| New | +$209K |
2022 Q4
0 quarters
|
|
|
4782
PUT
Darden Restaurants
DRI
$22.8B
| $207K | ﹤0.01% |
+1,500
| New | +$209K |
2022 Q4
0 quarters
|
|
4783
Mastech Digital
MHH
$83.2M
| $207K | ﹤0.01% |
18,790
-6,886
| -27% | -$95.6K |
2020 Q2
10 quarters
|
|
|
MSB
4784
Mesabi Trust
MSB
$247M
| $207K | ﹤0.01% |
11,495
-1,945
| -14% | -$38.6K |
2021 Q1
7 quarters
|
|
|
AIH
4785
DELISTED
Aesthetic Medical International Holdings
AIH
| $207K | ﹤0.01% |
156,529
| – | – |
2021 Q1
7 quarters
|
|
4786
KB Financial Group
KB
$44B
| $206K | ﹤0.01% |
5,339
+1,586
| +42% | +$57.3K |
2013 Q3
37 quarters
|
|
4787
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$121M
| $206K | ﹤0.01% |
913
| – | – |
2022 Q1
3 quarters
|
|
|
ORAN
4788
DELISTED
Orange
ORAN
| $206K | ﹤0.01% |
20,919
-2,320
| -10% | -$22.4K |
2013 Q2
38 quarters
|
|
4789
Cullinan Oncology
CGEM
$1.05B
| $205K | ﹤0.01% |
19,385
-524
| -3% | -$6.37K |
2021 Q1
7 quarters
|
|
4790
Oaktree Specialty Lending
OCSL
$1.03B
| $205K | ﹤0.01% |
9,968
-15,936
| -62% | -$321K |
2022 Q3
1 quarter
|
|
4791
Tucows
TCX
$102M
| $205K | ﹤0.01% |
6,042
+544
| +10% | +$19.7K |
2017 Q4
20 quarters
|
|
4792
Design Therapeutics
DSGN
$747M
| $203K | ﹤0.01% |
19,800
-73,352
| -79% | -$994K |
2021 Q2
6 quarters
|
|
4793
Greystone Housing Impact Investors LP
GHI
$124M
| $203K | ﹤0.01% |
11,881
-1
| -0% | -$18 |
2022 Q2
2 quarters
|
|
|
ELBM
4794
Electra Battery Materials
ELBM
$53.9M
| $202K | ﹤0.01% |
+10,839
| New | +$108K |
2022 Q2
2 quarters
|
|
|
TTSH
4795
DELISTED
Tile Shop Holdings
TTSH
| $202K | ﹤0.01% |
46,066
+1,835
| +4% | +$7.54K |
2021 Q2
6 quarters
|
|
4796
John Hancock Multifactor Large Cap ETF
JHML
$1.18B
| $201K | ﹤0.01% |
+4,079
| New | +$201K |
2022 Q4
0 quarters
|
|
4797
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.66B
| $201K | ﹤0.01% |
+2,811
| New | +$199K |
2022 Q4
0 quarters
|
|
4798
WisdomTree US AI Enhanced Value Fund
AIVL
$415M
| $200K | ﹤0.01% |
2,185
+546
| +33% | +$49.2K |
2014 Q4
32 quarters
|
|
4799
Colony Bankcorp
CBAN
$434M
| $200K | ﹤0.01% |
15,745
+796
| +5% | +$10.7K |
2019 Q1
15 quarters
|
|
4800
Oppenheimer Holdings
OPY
$1.32B
| $200K | ﹤0.01% |
4,730
+254
| +6% | +$9.35K |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.